<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31772304</article-id>
<article-id pub-id-type="pmc">7192855</article-id>
<article-id pub-id-type="publisher-id">604</article-id>
<article-id pub-id-type="doi">10.1038/s41380-019-0604-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Maternal Type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ben-Yehuda</surname>
<given-names>Hila</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matcovitch-Natan</surname>
<given-names>Orit</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kertser</surname>
<given-names>Alexander</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spinrad</surname>
<given-names>Amit</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0349-1955</contrib-id>
<name>
<surname>Prinz</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amit</surname>
<given-names>Ido</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Schwartz</surname>
<given-names>Michal</given-names>
</name>
<address>
<phone>+972-8-934-2467</phone>
<email>michal.schwartz@weizmann.ac.il</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0604 7563</institution-id><institution-id institution-id-type="GRID">grid.13992.30</institution-id><institution>Department of Neurobiology, </institution><institution>Weizmann Institute of Science, </institution></institution-wrap>Rehovot, Israel </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0604 7563</institution-id><institution-id institution-id-type="GRID">grid.13992.30</institution-id><institution>Department of Immunology, </institution><institution>Weizmann Institute of Science, </institution></institution-wrap>Rehovot, Israel </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.5963.9</institution-id><institution>Institute of Neuropathology, Faculty of Medicine, </institution><institution>University of Freiburg, </institution></institution-wrap>Freiburg, Germany </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5963.9</institution-id><institution>Signalling Research Centres BIOSS and CIBSS, </institution><institution>University of Freiburg, </institution></institution-wrap>Freiburg, Germany </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.5963.9</institution-id><institution>Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, </institution><institution>University of Freiburg, </institution></institution-wrap>Freiburg, Germany </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2020</year>
</pub-date>
<volume>25</volume>
<issue>5</issue>
<fpage>1050</fpage>
<lpage>1067</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Viral infection during pregnancy is often associated with neuropsychiatric conditions. In mice, exposure of pregnant dams to the viral mimetic poly(I:C), serves as a model that simulates such pathology in the offspring, through a process known as Maternal Immune Activation (MIA). To investigate the mechanism of such effect, we hypothesized that maternal upregulation of Type-I interferon (IFN-I), as part of the dam’s antiviral response, might contribute to the damage imposed on the offspring. Using mRNA sequencing and flow cytometry analyses we found that poly(I:C) treatment during pregnancy caused reduced expression of genes related to proliferation and cell cycle in the offspring’s microglia relative to controls. This was found to be associated with an IFN-I signature in the embryonic yolk sac, the origin of microglia in development. Neutralizing IFN-I signaling in dams attenuated the effect of MIA on the newborn’s microglia, while systemic maternal administration of IFNβ was sufficient to mimic the effect of poly(I:C), and led to increased vulnerability of offspring’s microglia to subsequent stress. Furthermore, maternal elevation of IFNβ resulted in behavioral manifestations reminiscent of neuropsychiatric disorders. In addition, by adopting a “two-hit” experimental paradigm, we show a higher sensitivity of the offspring to postnatal stress subsequent to the maternal IFNβ elevation, demonstrated by behavioral irregularities. Our results suggest that maternal upregulation of IFN-I, in response to MIA, interferes with the offspring’s programmed microglial developmental cascade, increases their susceptibility to postnatal stress, and leads to behavioral abnormalities.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Autism spectrum disorders</kwd>
<kwd>Neuroscience</kwd>
<kwd>Schizophrenia</kwd>
<kwd>Psychiatric disorders</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003977</institution-id>
<institution>Israel Science Foundation (ISF)</institution>
</institution-wrap>
</funding-source>
<award-id>1354/15</award-id>
<award-id>991/16</award-id>
<principal-award-recipient>
<name>
<surname>Schwartz</surname>
<given-names>Michal</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Advanced European Research Council (ERC-2016-ADG 741744). Consolidated Anti-Aging Foundation Chicago (2016-2017). Adelis Foundation (2018-2021).</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Nature Limited 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Viral infections during pregnancy increase the risk to the offspring of developing neuropsychiatric disorders, such as schizophrenia, autism, and bipolar disorders [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. To date, the mechanisms underlying such effects of maternal viral infections, which result in delayed-onset disorders, have not been fully elucidated.</p>
<p id="Par3">One of the common animal models used to study maternal viral infection outcomes is based on induction of maternal immune activation (MIA) by exposing the dam during pregnancy to the viral mimetic poly(I:C) [<xref ref-type="bibr" rid="CR8">8</xref>]. MIA includes upregulation of inflammatory cytokines [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR12">12</xref>], such as interleukin-6 (IL-6) that was shown to induce behavioral deficits in the offspring and to elicit changes in gene-expression in their brains [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. In addition, MIA causes upregulation of interferon beta (IFNβ) and interferon alpha (IFNα), members of the Type-I interferon (IFN-I) family [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], the first line of defense against viral infections in mammals [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]; yet, their possible contribution to the etiology of the offspring’s disorders is still unclear.</p>
<p id="Par4">An alternative model that was suggested as an explanation for the etiology of neuropsychiatric disorders is the Two-hit model, whereby two “hits” are required for the offspring disorder; a first “hit”, which occurs during prenatal life (such as MIA) disrupts the offspring’s CNS development, thereby increases the vulnerability to a second “hit”, which might occur later in life and would lead to the onset of disorder. In many cases the second “hit” could be an environmental factor such as psychological stress [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. Specifically, early life stress was found in humans as a risk factor that increases vulnerability to neuropsychiatric disorders, and in animal models, maternal separation paradigms are commonly used to study the outcomes of early life stress [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
<p id="Par5">Since microglia, the resident myeloid cells of the brain, play a vital role in development, and throughout life in homeostasis and pathology [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>], they might participate in the processes leading to neuropsychiatric conditions. During development, microglia shape neuronal circuits by elimination of synapses [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>] and by supporting and regulating neurogenesis [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In homeostasis, microglia engage mainly in immune surveillance [<xref ref-type="bibr" rid="CR33">33</xref>], while during pathology, the microglia become rapidly activated, secrete various cytokines, engage in phagocytic activity, regulate astrocyte pathogenic activity [<xref ref-type="bibr" rid="CR34">34</xref>], and can promote repair by secreting growth factors [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p id="Par6">Microglia are regulated by various factors within the central nervous system (CNS) microenvironment [<xref ref-type="bibr" rid="CR37">37</xref>]. Among them are transforming growth factor beta, which is important for shaping the fate of microglia during development [<xref ref-type="bibr" rid="CR38">38</xref>] and tightly controls their transcription profile in response to inflammatory signaling [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>], methyl-CpG binding protein 2, which regulates microglial response to inflammatory stimuli [<xref ref-type="bibr" rid="CR41">41</xref>], and interleukin-4, which stimulates microglial proliferation and modifies their inflammatory reaction following acute injury [<xref ref-type="bibr" rid="CR42">42</xref>]. IFNβ is another important regulator of microglia, and was shown to modify and affect microglial inflammatory responses. As such, IFNβ was shown to reduce microglial-mediated inflammation following spinal cord injury [<xref ref-type="bibr" rid="CR39">39</xref>] and to promote interleukin-10 production following activation of toll-like receptor (TLR)-3 combined with TLR-2/4/9 [<xref ref-type="bibr" rid="CR43">43</xref>]. However, prolonged phosphorylation of signal transducer and activator of transcription 1, a protein of the IFN-I cascade, leads to microgliopathy [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], and overexpression of IFNβ in the CNS, as occurs in ageing, induces an ageing-related microglial phenotype that is associated with cognitive impairment [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
<p id="Par7">Involvement of immune cells, such as the Th17 population, in promoting an autistic-like phenotype following MIA was shown [<xref ref-type="bibr" rid="CR4">4</xref>]; nevertheless, the role, if any, of microglia in contributing to the neuropsychiatric pathologies is still subject of debate [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]. Several studies that have linked defects in neuronal circuits, such as neuronal excitability and synaptic regulation, to neuropsychiatric disorders [<xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR54">54</xref>], suggest an active role for microglia in these pathologies [<xref ref-type="bibr" rid="CR55">55</xref>].</p>
<p id="Par8">Here, we hypothesized that the maternal elevation of IFN-I, in response to viral infection or viral mimetics, adversely affects the offspring’s microglia and behavior, which are also manifested with increased sensitivity to stressful conditions. We found that following MIA with poly(I:C), the newborn offspring showed reduced microglial proliferation, which was accompanied by an IFN-I signature. Furthermore, systemically blocking maternal IFN-I signaling decreased the effect of poly(I:C), while systemic maternal elevation of IFNβ was sufficient to reduce microglial proliferation in the newborn and to increase the vulnerability of the offspring’s microglia to postnatal stress. In addition, maternal elevation of IFNβ led to behavioral abnormalities in the offspring, and increased their sensitivity to postnatal stress. Overall, this study identifies IFN-I as an important regulator of the fate of microglia in early development, and as a factor that can induce neuropsychiatric-related behavior.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Animals</title>
<p id="Par9">C57BL/6J, interferon α/β receptor 1 knockout (IFNARKO) [<xref ref-type="bibr" rid="CR56">56</xref>] and CX3CR1-GFP mice [<xref ref-type="bibr" rid="CR57">57</xref>] were used. Females were mated at the age of 2–6 months. Newborn (postnatal day 0; P0) pups were treated as described (see below). For behavioral studies the mice were kept in a reverse light–dark cycle (lights off: 9:00–21:00). Animals were supplied by the Animal Breeding Center of the Weizmann Institute of Science. All animals were handled according to the regulations formulated by the Institutional Animal Care and Use Committee.</p>
</sec>
<sec id="Sec4">
<title>Maternal immune activation (MIA)</title>
<p id="Par10">Timed mating was performed to obtain embryos at defined time points after conception. Females with vaginal plugs were determined as pregnant at embryonic day 0.5 (E0.5). Females were intravenously (i.v.) injected on embryonic day 14.5 (E14.5) with a single dose of 5 mg/kg poly(I:C) (Sigma-Aldrich, Rehovot, Israel) dissolved in PBS, or an equivalent volume of PBS as a control. The dose of poly(I:C) was determined according to Meyer et al. 2008 [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. The injection volume was 5 ml/kg.</p>
</sec>
<sec id="Sec5">
<title>Maternal treatment with antibodies</title>
<p id="Par11">On E13.5, pregnant females were i.v. injected with a single dose of 400 µg anti-IFN receptor 1 (αIFNAR; MAR1-5A3 [<xref ref-type="bibr" rid="CR60">60</xref>], Bio X Cell, NH, USA) or control IgG (IgG1; MOPC-21, Bio X Cell, NH, USA) in 150 µl PBS. After 1 day, on E14.5, the treated females were injected with poly(I:C) or PBS, as described above.</p>
</sec>
<sec id="Sec6">
<title>Maternal treatment with interferon beta (IFNβ)</title>
<p id="Par12">On E14.5, pregnant females were i.v. injected with a single dose of 22,700 U [<xref ref-type="bibr" rid="CR61">61</xref>] or 45,400 U recombinant mouse IFNβ (PBL Assay Science, NJ, USA) dissolved in 100 µl vehicle (PBS supplemented with 0.1% FCS), or an equivalent volume of vehicle as a control.</p>
</sec>
<sec id="Sec7">
<title>Maternal treatment with interferon gamma (IFNγ)</title>
<p id="Par13">On E14.5, pregnant females were i.v. injected with a single dose of 5000 U [<xref ref-type="bibr" rid="CR62">62</xref>] recombinant mouse IFNγ (R&amp;D systems, MN, USA) dissolved in 100 µl vehicle (PBS supplemented with 0.1% FCS), or an equivalent volume of vehicle as a control.</p>
</sec>
<sec id="Sec8">
<title>Maternal treatment with tumor necrosis factor alpha (TNFα)</title>
<p id="Par14">On E14.5, pregnant females were i.v. injected with a single dose of 2.7 × 10<sup>5</sup> U (1 μg) [<xref ref-type="bibr" rid="CR63">63</xref>] recombinant mouse TNFα (R&amp;D systems, MN, USA) dissolved in 100 µl vehicle (PBS supplemented with 0.1% FCS), or an equivalent volume of vehicle as a control.</p>
</sec>
<sec id="Sec9">
<title>Maternal separation (MS)</title>
<p id="Par15">The protocol was performed as described [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR64">64</xref>] with small modifications. In brief, cages were randomly assigned to either MS or nonseparated control groups on the day of birth (P0). In the MS group, pups were separated daily from the dam for a period of 3 consecutive hours randomly during the light phase, from P1 to P14. The dam was first removed from her homecage and placed in a separate cage. All pups were then taken to another room, removed from their homecage and placed separately in small cages filled with clean bedding. Immediately afterwards the dam was returned to her homecage. After the 3 h separation period, the dam was again placed in a separate cage, then all the pups were returned to their homecage, immediately followed by the dam. The control group was left unattended with the dam in the homecage. During the protocol, all the cages were maintained and handled as regularly done in the animal facility.</p>
</sec>
<sec id="Sec10">
<title>Marble burying</title>
<p id="Par16">The behavioral test was performed to assess repetitive behavior [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Twenty glass marbles were placed in an arena sized 25 × 30 cm with 40 cm high walls, filled with clean bedding to a height of 3 cm. The mouse was placed in the arena for 30 min in a dimly-lighted room. Data were recorded using the EthoVision XT 11/14 automated tracking system (Noldus Information Technology). For analysis, the number of buried marbles was counted every 5 min. Marbles that were exposed after being buried were counted as buried. The investigator was blind to the identity of the animals throughout the experiments. Data were analyzed and codes were opened by a member of the team who did not perform the behavioral tests.</p>
</sec>
<sec id="Sec11">
<title>Elevated plus maze</title>
<p id="Par17">The exploration activity was measured to assess anxiety-related behavior [<xref ref-type="bibr" rid="CR67">67</xref>]. The mouse was placed in a plus shaped arena elevated 70 cm above the floor, in a lighted room. The sizes of the arms were 30 × 5 cm, while two of them were walled (15 cm high). The mouse was allowed freely to explore the arena for 5 min. Data were recorded using the EthoVision XT 11/14 automated tracking system (Noldus Information Technology). Time spent in the arms and the distance that the animal covered were measured. The investigator was blind to the identity of the animals throughout the experiments. Data were analyzed and codes were opened by a member of the team who did not perform the behavioral tests.</p>
</sec>
<sec id="Sec12">
<title>Social preference</title>
<p id="Par18">The social behavior of mice was assessed in the three-chamber arena [<xref ref-type="bibr" rid="CR68">68</xref>]. The arena (60 × 40 cm, 22 cm high walls) is comprised of three chambers of equal size with transparent plexiglass walls. The procedures were conducted in a dimly-lighted room; during the first trial, the mouse was allowed to freely explore the arena for 10 min of habitation, while concurrently, a stranger mouse was placed in a different enclosure, for habituation, inside a cylinder cage (8 × 13 cm) with bars that allow interaction. Subsequently, the tested mouse was guided to the center chamber, while the passages to the side chambers were blocked by opaque partition walls. The stranger mouse and a novel object were placed in each side-chamber of the arena, each inside a cylinder cage. The partition walls were then removed, and the tested mouse was allowed to freely explore the arena and the objects for 10 min. Time spent exploring each object was manually scored using EthoVision tracking system XT 14 (Noldus Information Technology), and percentage exploration of the stranger mouse (social preference) was calculated for each animal, by the formula: Percentage stranger exploration = ((stranger mouse exploration time)/(stranger mouse exploration time + novel object exploration time)) × 100%. The investigator was blind to the identity of the animals throughout the experiments. Data were analyzed and codes were opened by a member of the team who did not perform the behavioral tests.</p>
</sec>
<sec id="Sec13">
<title>Open field arena</title>
<p id="Par19">The exploration activity was measured to assess anxiety-related behavior [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. The mouse was placed in an 90 × 90 cm arena located in a lighted room, and allowed to freely explore for 10 min. Data were recorded using the EthoVision XT 14 automated tracking system (Noldus Information Technology). Time spent in arena center and total distance covered by the animal were calculated. The investigator was blind to the identity of the animals throughout the experiments. Data were analyzed and codes were opened by a member of the team who did not perform the behavioral tests.</p>
</sec>
<sec id="Sec14">
<title>Y-maze</title>
<p id="Par20">Spontaneous alternation behavior was recorded in a Y-maze to assess short-term memory performance [<xref ref-type="bibr" rid="CR71">71</xref>]. The apparatus was a symmetrical Y-maze; each arm measured 50 × 10 cm, with 40 cm high walls. Mice were placed in the maze, in a dimly-lighted room, and allowed to freely explore for 5 min. Data were recorded using the EthoVision XT 14 automated tracking system (Noldus Information Technology). Arms were arbitrarily labeled A, B, and C, and the sequence of arm entries was used to assess alternation behavior. An alternation was defined as consecutive entries into all three arms. The number of maximum alternations was therefore the total number of arm entries minus two, and the percentage of alternations was calculated as (actual alternations/maximum alternations) × 100. For example, for arms referred to as A, B, and C, if the mouse performed ABCABCABBAB, the number of arm entries would be 11, and the successive alternations: ABC, BCA, CAB, ABC, BCA, and CAB. Therefore, the percentage of alternations would be [6/(11 − 2)] × 100 = 66.7% [<xref ref-type="bibr" rid="CR72">72</xref>]. The investigator was blind to the identity of the animals throughout the experiments. Data were analyzed and codes were opened by a member of the team who did not perform the behavioral tests.</p>
</sec>
<sec id="Sec15">
<title>Flow cytometry and cell sorting</title>
<p id="Par21">Newborns (P0), P15 offspring, and dams (negative control group) were transcardially perfused with PBS; brains were dissected and stripped of choroid plexi. Newborn brains were striped of the meninges and cerebellum as well. Single-cell suspensions were achieved using software‐controlled sealed homogenization system (Dispomix®, Medic Tools; Miltenyi) in PBS. For density gradient separation, the pellet was mixed with 40% Percoll and centrifuged at 800 <italic>g</italic> for 20 min at room temperature. For newborn’s microglial Ki67 experiments, single-cell suspensions, following the density gradient separation, were taken for fixation and permeabilization using Cytofix/Cytoperm (BD Biosciences) for 20 min at 4 °C, and washed gently with BD-perm buffer (BD Biosciences). Next, samples were blocked with Fc‐block CD16/32 (BD Biosciences, San Jose, CA) in the presence of 20% donkey serum (10 min at 4 °C), stained and analyzed on a FACS-LSRII cytometer (BD Biosciences) using BD FACSDIVA (BD Biosciences) and FlowJo (FlowJo, LLC) software.</p>
<p id="Par22">For newborn’s microglia sorting experiments, single-cell suspensions, following the density gradient separation, were blocked with Fc‐block CD16/32, and stained. CD11b<sup>int</sup>CD45<sup>int</sup> or CD11b<sup>int</sup>CD45<sup>int</sup>CX3CR1<sup>+</sup> microglia were sorted with SORP-aria (BD Biosciences, San Jose, CA) into 80 μl of Lysis/Binding buffer (Invitrogen).</p>
<p id="Par23">For intracellular TNFα detection in microglia of P15 pups, single-cell suspensions, following density gradient separation, were incubated with DMEM (Biological Industries) supplemented with 5% FCS, 1 mM <sc>l</sc>-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, and Golgi-stop (1:1000; BD Biosciences) for 3 h at 37 °C, to enable expression of intracellular cytokines, and to prevent their extracellular secretion. Cells were washed, fixed, permeabilized, and stained for surface and intracellular proteins, using Cytofix/Cytoperm kit, according to the manufacturer’s instructions.</p>
<p id="Par24">The following antibodies were used: BV421-conjugated CD45 (1:150), APC-conjugated CD11b (1:200), PE-conjugated Ki67 (1:150), PE-conjugated CX3CR1 (1:150), APC-conjugated Ly6C (1:150), BV711-conjugated CX3CR1 (1:150), and PE-conjugated TNFα (1:50; all from Biolegend Inc.), and PE-conjugated isotype control Rat IgG1 (1:50; BD Pharmingen).</p>
</sec>
<sec id="Sec16">
<title>Immunofluorescence</title>
<p id="Par25">Mice were transcardially perfused with PBS before tissue excision and fixation. Tissue processing and immunofluorescence analysis were performed on paraffin-embedded, sectioned (6 μm thick) mouse brains. The following primary antibodies were used: rabbit anti-IFNAR1 (1:50; Abcam), biotinylated-goat anti-GFP (1:150; Abcam), and rabbit anti-IBA1 (1:150; Wako). Secondary antibodies were Cy2-conjugated streptavidin (1:150; Jackson ImmunoResearch), Cy2-conjugated donkey anti-rabbit (1:150; Jackson ImmunoResearch), and Cy3-conjugated donkey anti-rabbit antibodies (1:200; Jackson ImmunoResearch).</p>
<p id="Par26">A Nikon Eclipse 80i fluorescence microscope was used for microscopic analysis. The fluorescence microscope was equipped with a digital camera (DXM 1200F; Nikon) and with 20× NA 0.50 and 40× NA 0.75 objective lenses (Plan Fluor; Nikon). Recordings were made using acquisition software (NIS-Elements, F3).</p>
<p id="Par27">Prior to quantification, slices were coded to mask the identity of the experimental groups, and cell intensity was quantified by an observer blinded to the origin of the sample, using Fiji software (ImageJ 1.51w; NIH); the “IntDen” parameter with threshold detection of 94–255 was used to quantify intensity. Five representative images from different depths in the brain were used to calculate the average fluorescence intensity per mouse. Representative images were cropped, merged, and optimized using Photoshop CS6 13.0.1 (Adobe), and were arranged using Illustrator CC 17.0 (Adobe).</p>
</sec>
<sec id="Sec17">
<title>RNA purification and library preparation</title>
<p id="Par28">mRNA was captured with 12 µl of Oligo(dT) Dynabeads (Life Technologies), washed, and eluted at 70 °C with 10 µl of 10 mM Tris-Cl (pH 7.5). RNA-seq was performed as previously described [<xref ref-type="bibr" rid="CR73">73</xref>] and DNA libraries were sequenced on an Illumina NextSeq 500 or HiSeq with an average of 4 million aligned reads per sample.</p>
</sec>
<sec id="Sec18">
<title>RNA-sequencing (RNA-seq) processing and analysis</title>
<p id="Par29">RNA-seq of newborns following treatment was compared with controls. For the RNA-seq analysis shown in Fig. <xref ref-type="fig" rid="Fig1">1</xref>, we analyzed our previous data from Matcovitch-Natan et al. 2016 [<xref ref-type="bibr" rid="CR74">74</xref>]. The RNA-seq reads were aligned to the mouse reference genome (NCBI 37, mm9) using TopHat v2.0.13 with default parameters [<xref ref-type="bibr" rid="CR75">75</xref>]. Duplicate reads were filtered if they aligned to the same base and had identical UMIs. Expression levels were calculated and normalized for each sample to the total number of reads using HOMER software (<ext-link ext-link-type="uri" xlink:href="http://homer.salk.edu">http://homer.salk.edu</ext-link>) with the command “analyzeRepeats.pl rna mm9-d [sample files]-count 3utr-condenseGenes” [<xref ref-type="bibr" rid="CR76">76</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Type-I IFN is associated with reduced offspring’s microglia proliferation and with embryonic yolk sac response following MIA. <bold>a</bold> Schematic presentation of the model used to assess microglial fate: Poly(I:C) (5 mg/kg) or PBS (control) was i.v. injected to pregnant females at embryonic day 14.5 (E14.5), and newborn’s microglia were examined by RNA-seq (published data of Matcovitch-Natan et al. 2016 [<xref ref-type="bibr" rid="CR74">74</xref>] was analyzed in this study), and by flow cytometry. <bold>b</bold> Volcano plot for the RNA-seq data shows the fold change and significance of genes between microglia of newborn offspring of dams treated with poly(I:C) or PBS [190 genes significantly downregulated (blue) and 404 significantly upregulated (red)]. <bold>c</bold> Gene ontology (GO) analysis [<xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR80">80</xref>] for RNA-seq shows reduction of terms related to cell cycle and proliferation in microglia derived from newborn progeny of poly(I:C) treated mice. <bold>d</bold> “Interferome” analysis [<xref ref-type="bibr" rid="CR81">81</xref>] of the RNA-seq results. Three hundred and eighty-four of the affected genes were regulated by Type I and II interferons, while the majority were genes affected specifically by Type-I interferon. IFNβ had the greatest effect, compared with IFNα. <bold>e</bold> Flow cytometry gating strategy for Ki67<sup>+</sup> microglia. <bold>f</bold> Flow cytometry analyses showing percentage of microglia expressing the proliferation marker, Ki67 (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 5.789<italic>, df</italic> = 14<italic>, ***p</italic> &lt; 0.001), and <bold>g</bold> normalized number of microglia (to 20,000 live-gate events). <bold>f</bold>, <bold>g</bold> Representative results of one of two independent experiments. Data are presented as means ± s.e.m. <italic>n</italic> = 8 newborns per group. <bold>h</bold> Immunofluorescence staining confirming IFNAR1 expression in CX3CR1-GFP<sup>+</sup> microglia in the newborn’s brain. Scale bar, 50 µm. <bold>i</bold> Embryonic yolk sacs, the source of microglial progenitors, were excised 1 day following MIA and were analyzed by RTqPCR. <bold>j</bold> RTqPCR results showing percent changes of genes following MIA compared with PBS control. <bold>i</bold>, <bold>j</bold> Representative results of one of two independent experiments. Data are presented as means ± s.e.m. <italic>n</italic> = 7–8 yolk sacs per group. <italic>*p</italic> &lt; 0.05; <italic>**p</italic> &lt; 0.01; <italic>***p</italic> &lt; 0.001</p></caption><graphic id="d29e763" xlink:href="41380_2019_604_Fig1_HTML"></graphic></fig></p>
<p id="Par30">Using Microsoft Excel we focused on genes with mean expression above noise (set at 64), that were differentially expressed (with 1.5-fold differential, log fold change = 0.585) between the means of the groups (two-tailed Student’s <italic>t</italic> test, <italic>P</italic> &lt; 0.01).</p>
<p id="Par31">Gene ontology (GO) associations [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>] were determined using GOrilla [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>], to which gene symbols of significantly increased or decreased genes (as a target set) and a complete gene list (as a background set) were imported. Interferon related genes were determined using “interferome” [<xref ref-type="bibr" rid="CR81">81</xref>].</p>
</sec>
<sec id="Sec19">
<title>RTqPCR</title>
<p id="Par32">Pregnant females at E15.5 were transcardially perfused with PBS, and yolk sacs were extracted. Total RNA was extracted with the RNeasy kit according to the manufacturer’s instructions (Qiagen). RNA was reverse transcribed using the high capacity cDNA reverse transcription kit (Applied Biosystems), amplified using SYBR green I Master Mix (Roche), and detected by StepOnePlus (Applied Biosystems), in duplicates. Results were normalized to the expression of the housekeeping gene, peptidylprolyl isomerase-A (PPIA), and then expressed as percent change relative to the control sample. The following primers were used:</p>
<p id="Par33"><italic>ppia</italic> forward, 5′-AGCATACAGGTCCTGGCATCTTGT-3, and reverse, 5′-CAAAGACCACATGCTTGCCATCCA-3′;</p>
<p id="Par34"><italic>cx3cr1</italic> forward, 5′-CTTCCCATCTGCTCAGGAC-3, and reverse, 5′- ACAATGTCGCCCAAATAACAG-3′;</p>
<p id="Par35"><italic>cd45</italic> forward, 5′-CTATGAGCAATACCAGTTCCTC-3′, and reverse, 5′- GGACGGACACAGTTAGCA-3′;</p>
<p id="Par36"><italic>cd11b</italic> forward, 5′-TTCAGCAAGCCAGAACCC-3′, and reverse, 5′- CTCAGAATTAGCAGGAAAGATGG-3′;</p>
<p id="Par37"><italic>ifnβ</italic> forward, 5′-GAATTCGACGTCGGTACCTC-3′, and reverse, 5′-AGGGAACAGCTATGACCATGA-3′;</p>
<p id="Par38"><italic>irf3</italic> forward, 5′-CTCTGTGGTTCTGCATGGG -3′, and reverse, 5′-TGTAGGAACAACCTTGACCA-3′;</p>
<p id="Par39"><italic>irf7</italic> forward, 5′-CTTCAGCACTTTCTTCCGAGA-3′, and reverse, 5′-TGTAGTGTGGTGACCCTTGC-3′;</p>
<p id="Par40"><italic>irf9</italic> forward, 5′-AACCCTCCCTAACCAACCAC-3′, and reverse, 5′- GGTTTACAACGCCATTGGTC-3′;</p>
<p id="Par41"><italic>ifit1</italic> forward, 5′-CTTTACAGCAACCATGGGAGAG-3′, and reverse, 5′- TCCATGTGAAGTGACATCTCAG-3’;</p>
<p id="Par42"><italic>ifitm3</italic> forward, 5′-CTGGTCCCTGTTCAATACAC-3′, and reverse, 5′-TTCCGATCCCTAGACTTCAC-3′;</p>
<p id="Par43"><italic>il-β</italic> forward, 5′-ACCTGTCCTGTGTAATGAAAGAC-3′ and reverse, 5′-TGGGTATTGCTTGGGATCCA-3′.</p>
<p id="Par44"><italic>tnfα</italic> forward, 5′-CCCTCACACTCAGATCATCTTCT-3′, and reverse, 5′-GCTACGACGTGGGCTACAG- 3′;</p>
<p id="Par45"><italic>il-6</italic> forward, 5′-TGCAAGAGACTTCCATCCAGTTG-3′ and reverse, 5′-TAAGCCTCCGACTTGTCAAGTGGT-3′.</p>
</sec>
<sec id="Sec20">
<title>Statistics</title>
<p id="Par46">One or two-tailed Student’s <italic>t</italic> tests were used, as indicated in the figure legends. *<italic>p</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001. Cohen’s <italic>d</italic> was calculated using the conventional formula. Sample sizes were chosen with adequate statistical power based on the literature and past experience, and mice were allocated randomly to experimental groups. Data were excluded only if one of the parameters of the samples was exceeding at least two standard deviations above/below average. Results are presented as mean ± s.e.m. In the graphs, <italic>y</italic>-axis error bars represent s.e.m. Statistical calculations were performed using GraphPad Prism software (GraphPad Software, San Diego, CA).</p>
</sec>
</sec>
<sec id="Sec21" sec-type="results">
<title>Results</title>
<sec id="Sec22">
<title>Offspring’s microglia show reduced proliferation and a Type-I interferon signature following maternal immune activation</title>
<p id="Par47">In our paper by Matcovitch-Natan et al. 2016 [<xref ref-type="bibr" rid="CR74">74</xref>], we demonstrated an early maturation of newborn’s microglia following MIA. The MIA was induced by injecting pregnant females, on embryonic day 14.5 (E14.5), with poly(I:C) (5 mg/kg) or PBS, as control (the paradigm used is schematically shown in Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). Since a viral infection, or administration of the viral mimetic poly(I:C), results in a general upregulation of inflammatory cytokines [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR12">12</xref>], including IFN-I [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], we envisioned that the effect of MIA on the newborn’s microglia might involve IFN-I signaling. To investigate this, we further analyzed RNA-seq data from our previous paper derived from microglia of newborn mice following MIA [<xref ref-type="bibr" rid="CR74">74</xref>]. We found 594 genes with highly divergent expression between the treated and control groups (190 downregulated and 404 upregulated; Fig. <xref ref-type="fig" rid="Fig1">1b</xref>, Supplementary Table <xref ref-type="media" rid="MOESM4">1</xref>). GO analysis [<xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR80">80</xref>] revealed that newborn’s microglia derived from the poly(I:C) group showed lower expression levels of genes related to cell cycle and proliferation (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>). In order to test whether the effect of MIA on microglia could be IFN-dependent, we analyzed the RNA-seq results using “Interferome”, the database of IFN-regulated genes [<xref ref-type="bibr" rid="CR81">81</xref>]. This analysis revealed that approximately two-thirds of the differentially expressed genes (384 genes) are regulated by Type I and II interferons, out of which the majority are genes affected by Type I interferon (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>). Specifically, the analysis showed that IFNβ had the greatest effect, compared with IFNα, on newborn’s microglial gene expression following MIA (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>).</p>
<p id="Par48">To confirm the RNA-seq results, we repeated the same MIA procedure and examined the newborn’s microglia for protein expression of the proliferation marker Ki67 by flow cytometry (Fig. <xref ref-type="fig" rid="Fig1">1a, e–g</xref>). Microglia from the brains of the dams were used as a negative control, due to their negligible Ki67 expression (Fig. <xref ref-type="fig" rid="Fig1">1e</xref>). We found that a significantly lower percentage of microglia derived from offspring of poly(I:C)-treated dams expressed Ki67, as compared with the percentage of microglia derived from offspring of PBS-treated animals (Fig. <xref ref-type="fig" rid="Fig1">1f</xref>). Cell quantification showed a trend toward a reduction in the total number of microglia following MIA (Fig. <xref ref-type="fig" rid="Fig1">1g</xref>). These results demonstrated that MIA resulted in reduced proliferation of newborn’s microglia.</p>
<p id="Par49">Next, we assessed whether newborn’s microglia could be affected by IFN-I produced by the dams in response to poly(I:C), as a possible mechanism underlying the effect of MIA (Fig. <xref ref-type="fig" rid="Fig1">1b, d</xref>). Accordingly, we checked, using immunofluorescence, whether newborn’s microglia express IFN receptor 1 (IFNAR1). We found that CX3CR1<sup>+</sup> microglia express IFNAR1 (Fig. <xref ref-type="fig" rid="Fig1">1h</xref>), and thus could respond to IFN-I. These results show that MIA downregulates microglial proliferation, and that this effect might involve IFN-I signaling.</p>
</sec>
<sec id="Sec23">
<title>Maternal immune activation elicits a Type-I interferon response in the embryonic yolk sac</title>
<p id="Par50">The results above led us to hypothesize that if the effect on newborn’s microglia following MIA is mediated through maternal IFN-I, we might detect the IFN-I signature in the yolk sac, the source of microglial progenitors [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>], at an early time point after the MIA. To this end, pregnant females were injected on E14.5 with poly(I:C) or PBS, and 24 h later, the embryonic yolk sac was excised and analyzed by RTqPCR (Fig. <xref ref-type="fig" rid="Fig1">1i</xref>). We detected increased expression levels of IFN-I-dependent genes [including IFN-β 1 (<italic>ifnβ</italic>), IFN regulatory factor 3 (<italic>irf3</italic>), IFN regulatory factor 7 (<italic>irf7</italic>), IFN regulatory factor 9 (<italic>irf9</italic>), IFN-induced protein with tetratricopeptide repeats 1 (<italic>ifit1</italic>), and IFN-induced transmembrane protein 3 (<italic>ifitm3</italic>)] following MIA (Fig. <xref ref-type="fig" rid="Fig1">1j</xref>). Changes in other genes were detected as well, such as NF-kB-dependent inflammatory cytokines [interleukin 1 beta (<italic>il-1β</italic>), tumor necrosis factor alpha (<italic>tnfα</italic>), and interleukin 6 (<italic>il-6</italic>)] [<xref ref-type="bibr" rid="CR84">84</xref>] and the myeloid markers <italic>cd45</italic> and <italic>cd11b</italic> [<xref ref-type="bibr" rid="CR85">85</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1j</xref>). These results revealed an IFN-I signature in the offspring at an early time point following MIA.</p>
</sec>
<sec id="Sec24">
<title>IFN-I is an important regulator of microglial proliferation</title>
<p id="Par51">To get a deeper insight into the role of IFN-I during development, we tested whether IFN-I has a homeostatic role in regulating microglial proliferation, using IFNARKO mice [<xref ref-type="bibr" rid="CR56">56</xref>]. We first compared the basal microglial proliferation in WT and IFNARKO offspring of nontreated dams. Analysis of Ki67 by flow cytometry revealed that a significantly higher percentage of IFNARKO microglia expressed the proliferation marker, as compared with the WT microglia (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>). A trend toward an increase in total numbers of microglia was also detected (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>). These results suggested that IFN-I participates in the normal regulation of microglial proliferation, and raised the question of whether the newborn’s microglial response to MIA would be different in the absence of IFN-I signaling. To this end, pregnant IFNARKO dams were exposed to poly(I:C) or PBS, and flow cytometry analysis for expression of the proliferation marker Ki67 by newborn’s microglia was performed. We found that following MIA, a significantly higher percentage of IFNARKO newborn’s microglia expressed Ki67, as compared with the PBS-treated group (Fig. <xref ref-type="fig" rid="Fig2">2c</xref>). Cell quantification showed a significant increase in total number of microglia, as well (Fig. <xref ref-type="fig" rid="Fig2">2d</xref>). RNA-seq of sorted IFNARKO newborn’s microglia from poly(I:C) and PBS groups supported the flow cytometry results (Fig. <xref ref-type="fig" rid="Fig2">2e, f</xref>); comparison of poly(I:C) to PBS IFNARKO newborn’s microglia showed highly divergent expression of 405 genes (175 upregulated and 230 downregulated; Fig. <xref ref-type="fig" rid="Fig2">2e</xref>, Supplementary Table <xref ref-type="media" rid="MOESM5">2</xref>). GO analysis [<xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR80">80</xref>] showed enrichment of genes related to proliferation and cell cycle in IFNARKO newborn’s microglia following the poly(I:C) treatment, compared with the PBS group (Fig. <xref ref-type="fig" rid="Fig2">2f</xref>). The results supported the possibility that IFN-I signaling is involved in regulating newborn’s microglial proliferation in homeostasis. Notably, in the absence of IFN-I signaling, MIA caused an increase in proliferation of newborn’s microglia, and thus elicited a response opposite to that in WT mice. These results further suggest that additional factors, beyond IFN-Ι, participate in regulating microglial proliferation, such as the NF-kB-dependent inflammatory cytokines, IL-1β, TNFα, and IL-6 (Fig. <xref ref-type="fig" rid="Fig1">1j</xref>), that might be masked in the presence of IFN-I signaling.<fig id="Fig2"><label>Fig. 2</label><caption><p>IFN-I regulates microglial proliferation. <bold>a</bold> Flow cytometry analyses showing percentage of C57 and IFNARKO newborn’s microglia expressing the proliferation marker Ki67 (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 4.524<italic>, df</italic> <italic>=</italic> 9<italic>, **p</italic> = 0.0014<italic>)</italic>, and <bold>b</bold> normalized number of microglia (to 35,000 live-gate events. Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.603<italic>, df</italic> = 9<italic>, p</italic> = 0.0717). Representative results of one of two independent experiments. Data are presented as means ± s.e.m. <italic>n</italic> = 5–6 newborns per group. <bold>c</bold> Flow cytometry analyses showing percentage of IFNARKO newborn’s microglia expressing the proliferation marker Ki67 (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 2.934<italic>, df</italic> = 22<italic>, **p</italic> = 0.0077), and <bold>d</bold> normalized number of microglia (to 40,000 live-gate events. Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 3.3237<italic>, df</italic> = 22<italic>, **p</italic> = 0.0038) following MIA. Representative results of one of two independent experiments. Data are presented as means ± s.e.m. <italic>n</italic> = 12 newborns per group. <bold>e</bold> Volcano plot for RNA-seq data shows the fold change and significance of genes of IFNARKO newborn offspring of dams treated with either poly(I:C) or PBS [175 genes significantly upregulated (red) and 230 significantly downregulated (blue)]. <bold>f</bold> Gene ontology (GO) analysis [<xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR80">80</xref>] of the RNA-seq results showing enrichment of terms related to proliferation and cell cycle following the poly(I:C) treatment</p></caption><graphic id="d29e1167" xlink:href="41380_2019_604_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec25">
<title>Maternal IFNβ signaling downregulates newborn’s microglial proliferation</title>
<p id="Par52">To validate the active involvement of IFN-I, elicited by the dams in response to MIA, in impairing newborn’s microglia, we tested whether blocking IFN-I signaling prior to poly(I:C) treatment would mitigate the effect of MIA on newborn’s microglial proliferation. For this purpose, we used antibodies to block the maternal-IFN-I signaling in WT dams. Specifically, pregnant C57 dams were injected 1 day prior to poly(I:C) treatment [on embryonic day 13.5 (E13.5)], with anti-IFN receptor 1 (αIFNAR; MAR1-5A3 [<xref ref-type="bibr" rid="CR60">60</xref>], 400 µg) or IgG (IgG1; MOPC-21, 400 µg), to allow efficient blockade before the MIA-induced IFN-I effect on the offspring (Fig. <xref ref-type="fig" rid="Fig1">1i, j</xref>). Subsequently, the newborn’s microglia were isolated and tested (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). The control group was injected with IgG on E13.5 and with PBS on E14.5 (IgG–PBS group) to determine the basal levels of microglial proliferation and cell numbers (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). Flow cytometry analysis of newborn’s microglia for the proliferation marker Ki67 showed that maternal treatment with αIFNAR prior to MIA [αIFNAR-Poly(I:C)] diminished the negative effect of MIA on microglial proliferation, as compared with the group that was treated with IgG prior to the poly(I:C) [IgG-Poly(I:C); Fig. <xref ref-type="fig" rid="Fig3">3b</xref>]. No changes in the total number of microglia were apparent (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Maternal IFNβ signaling downregulates newborn’s microglial proliferation. <bold>a</bold> Pregnant females were i.v. injected on E13.5 with 400 µg αIFNAR (αIFNAR; MAR1-5A3) or IgG (IgG1; MOPC-21), and 1 day later, on E14.5 with poly(I:C). Females from the control group were injected with IgG on E13.5 and with PBS on E14.5 (IgG-PBS) to determine the basal levels of microglial proliferation and cell numbers. The newborn’s microglia were analyzed by flow cytometry. <bold>b</bold> Flow cytometry analyses showing percentage of microglia expressing the proliferation marker Ki67 (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.735<italic>, df</italic> = 22<italic>, *p</italic> = 0.0484), and <bold>c</bold> normalized number of microglia (to 30,000 live-gate events). Dashed line represents the IgG–PBS control average. Combined results from two different experiments. Data are presented as means ± s.e.m. <italic>n</italic> = 12 newborns per group. <bold>d</bold> Pregnant dams were i.v. injected with IFNβ (22,700 U) or vehicle on E14.5, and newborn’s microglia were examined by RNA-seq and by flow cytometry. <bold>e</bold> Volcano plot for RNA-seq data shows the fold change and significance of gene expression between microglia of newborn offspring of dams treated IFNβ or vehicle [257 significantly downregulated (blue) and 57 significantly upregulated (red)]. <bold>f</bold> Flow cytometry analyses showing percentage of microglia expressing the proliferation marker Ki67 following maternal vehicle and IFNβ treatments (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 3.139<italic>, df</italic> = 10<italic>, *p</italic> = 0.0105), and <bold>g</bold> normalized number of microglia (to 20,000 live-gate events). Representative results of one of two independent experiments. Data are presented as means ± s.e.m. <italic>n</italic> = 6 newborns per group. <bold>h</bold> Flow cytometry analyses showing percentage of microglia expressing the proliferation marker Ki67 following maternal vehicle and IFNγ treatments, and <bold>i</bold> normalized number of microglia (normalized to 30,000 live-gate events. Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 2.339<italic>, df</italic> = 14<italic>, *p</italic> = 0.0347). Representative results of one of two independent experiments. Data are presented as means ± s.e.m. <italic>n</italic> = 8 newborns per group. <bold>j</bold> Flow cytometry analyses showing percentage of microglia expressing the proliferation marker Ki67 following maternal vehicle and TNFα treatments, and <bold>k</bold> normalized number of microglia (to 60,000 live-gate events). Data are presented as means ± s.e.m. <italic>n</italic> = 13–16 newborns per group</p></caption><graphic id="d29e1291" xlink:href="41380_2019_604_Fig3_HTML"></graphic></fig></p>
<p id="Par53">These results prompted us to examine whether maternal elevation of IFN-I could, by itself, mimic the effect of MIA on microglial proliferation in the offspring. Since our “interferome” analysis showed that IFNβ had the greatest effect among the IFN-I family members on newborn’s microglial gene expression following MIA (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>), we decided to use this cytokine for our subsequent experiments. Pregnant dams were injected at E14.5 with IFNβ (22,700 U) [<xref ref-type="bibr" rid="CR61">61</xref>] or vehicle, as a control (see Materials and Methods), and the microglia of newborn offspring were examined (Fig. <xref ref-type="fig" rid="Fig3">3d</xref>). We first verified the signature of the maternal IFNβ treatment on the microglia of the offspring by RNA-seq. Analysis revealed 57 and 257 genes that exhibited at least 1.5-fold increased or decreased expression, respectively, in offspring of IFNβ-treated dams, compared with vehicle-injected controls (Fig. <xref ref-type="fig" rid="Fig3">3e</xref>, Supplementary Table <xref ref-type="media" rid="MOESM6">3</xref>). We detected upregulation of various genes related to inflammation, IFN signaling, and the viral response (e.g., <italic>ctla2b, lmln, ddit4,</italic> and <italic>gpr65</italic>). Next, we assessed the proliferation of newborn’s microglia by flow cytometry. A significantly lower percentage of microglia expressed Ki67 following maternal IFNβ injection, as compared with controls (Fig. <xref ref-type="fig" rid="Fig3">3f</xref>). No change in the total number of microglia was detected (Fig. <xref ref-type="fig" rid="Fig3">3g</xref>). These results demonstrated that the mere maternal elevation of IFNβ was sufficient to induce an effect on the microglia of the offspring, which was manifested by their reduced proliferation.</p>
<p id="Par54">Because other factors are likely involved in the regulation of the newborn’s microglia (Figs. <xref ref-type="fig" rid="Fig1">1i, j</xref> and <xref ref-type="fig" rid="Fig2">2</xref>), and in order to determine whether maternal IFNβ uniquely reduces their proliferation, we assessed the effect of additional cytokines. To this end, we injected pregnant dams at E14.5 with interferon gamma (IFNγ; 5000 U [<xref ref-type="bibr" rid="CR62">62</xref>]), a Type-II interferon member (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>), or with TNFα [2.7 × 10<sup>5</sup> U (1 μg) [<xref ref-type="bibr" rid="CR63">63</xref>]], an NF-kB-dependent inflammatory cytokine (Fig. <xref ref-type="fig" rid="Fig1">1j</xref>). Analyses by flow cytometry reveled that maternal treatment with IFNγ did not elicit a change in percentage of newborn’s microglia expressing Ki67 (Fig. <xref ref-type="fig" rid="Fig3">3h</xref>), however, a higher number of microglial cells was observed (Fig. <xref ref-type="fig" rid="Fig3">3i</xref>). Analyses of the newborn’s microglia following maternal TNFα treatment, did not show any change in percentage of microglia expressing Ki67, nor in number of microglial cells (Fig. <xref ref-type="fig" rid="Fig3">3j, k</xref>). These results suggest that although many factors could be involved in regulation of microglia, IFNβ seems to uniquely reduce their proliferation.</p>
</sec>
<sec id="Sec26">
<title>Elevated IFNβ during pregnancy imposes behavioral abnormalities in the offspring</title>
<p id="Par55">The results above encouraged us to examine whether the prenatal exposure to IFNβ would have any effect on the behavior of the offspring at adolescence and adulthood (Fig. <xref ref-type="fig" rid="Fig4">4</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM2">1</xref>). For this purpose, pregnant dams were injected on E14.5 with vehicle or a high dose of IFNβ (45,400 U) to elicit a strong response, and behavior of the offspring was assessed. Specifically, at the age of 1 month we evaluated the repetitive behavior and anxiety of the offspring using marble burying and elevated plus maze tests [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. At the age of 3 months the offspring were tested for sociability by social preference test [<xref ref-type="bibr" rid="CR68">68</xref>], and again by marble burying and elevated plus maze tests. At the age of 4 months the offspring were tested for anxiety by open field arena [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>] and for working memory by spontaneous alternation test in the Y-maze [<xref ref-type="bibr" rid="CR71">71</xref>] (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>). Overall, we found different response of the sexes to the maternal IFNβ treatment. In female offspring, we found at the age of 1 month that the IFNβ group buried a significantly higher number of marbles in the first 5 min of the marble burying test, as compared with the control group (Fig. <xref ref-type="fig" rid="Fig4">4b</xref>). At the age of 3 months, we found a significant reduction in social preference following maternal IFNβ treatment (Fig. <xref ref-type="fig" rid="Fig4">4c, d</xref>), and at 4 months we found a significantly higher percentage of spontaneous alternation, compared with the control group (Fig. <xref ref-type="fig" rid="Fig4">4e</xref>). In male offspring, we found at the age of 3 months, reduced exploration time of open arms in the elevated plus maze following maternal IFNβ treatment (Fig. <xref ref-type="fig" rid="Fig4">4f, g</xref>). This was not due to reduced distance covered by the animals (Fig. <xref ref-type="fig" rid="Fig4">4h</xref>). At the age of 4 months, we detected a trend toward reduced time spent at the center of the open field arena following the maternal treatment, which was not accompanied by change in total distance covered by the animals (Fig. <xref ref-type="fig" rid="Fig4">4i, j</xref>). These results demonstrate that maternal upregulation of IFNβ is manifested by changes in behavior of the offspring with different characteristics in females and males.<fig id="Fig4"><label>Fig. 4</label><caption><p>Maternal elevation of IFNβ leads to behavioral abnormalities in offspring. <bold>a</bold> Pregnant females were i.v. injected on E14.5 with IFNβ (45,400 U) or vehicle. At the age of 1 month, the offspring were tested by marble burying and elevated plus maze tests. At the age of 3 months the offspring were tested by social preference, marble burying, and elevated plus maze tests. At the age of 4 months the offspring were tested by open field arena and by spontaneous alternation (Y-maze) tests. <bold>b</bold> Number of buried marbles by 1-month-old female offspring of dams treated with vehicle versus IFNβ, during the first 5 min of the marble burying test (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub>= 1.903, <italic>df</italic> = 12, *<italic>p</italic> = 0.0406). <bold>c</bold> Percent stranger exploration time by 3-month-old female offspring in social preference test (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 2.446<italic>, df</italic> = 13<italic>, *p</italic> = 0.0294), and <bold>d</bold> representative heatmaps. STR -stranger mouse, OBJ -novel object. <bold>e</bold> Percent spontaneous alternation in Y-maze by 4-month-old female offspring (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.808<italic>, df</italic> = 13<italic>, *p</italic> = 0.0469). <bold>f</bold> Time spent in open arms of the elevated plus maze by 3-month-old male offspring (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 2.212<italic>, df</italic> = 13<italic>, *p</italic> = 0.0455), and <bold>g</bold> representative heatmaps. <bold>h</bold> Total distance of 3-month-old male offspring in the elevated plus maze arena. <bold>i</bold> Time spent in the center of the open field arena by 4-month-old male offspring (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.410<italic>, df</italic> = 13<italic>, p</italic> = 0.091), and <bold>j</bold> total distance covered in the arena. Data are presented as means ± s.e.m. <italic>n</italic> = 5–10 offspring of 2–3 dams per group</p></caption><graphic id="d29e1523" xlink:href="41380_2019_604_Fig4_HTML"></graphic></fig></p>
</sec>
<sec id="Sec27">
<title>Elevated IFNβ during pregnancy increases the vulnerability of the offspring and their microglia to postnatal stress</title>
<p id="Par56">Finally, we examined whether the exposure to the upregulated maternal IFNβ during pregnancy renders the offspring’s microglia less resilient to stressful conditions. We envisioned that this would be in line with the “Two-hit” model of neuropsychiatric disorders, according to which two “hits” are required for the pathology to occur; a first “hit” during prenatal life disrupts the offspring’s CNS development, thereby causes increased vulnerability to a second “hit”, which might occur later in life and would lead to the pathological onset of disease [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. To this end, pregnant dams were injected on E14.5 with vehicle or a high dose of IFNβ (45,400 U) (first “hit”), and the newborn pups were subsequently subjected to a 2-week maternal separation (MS) protocol [on postnatal days 1–14 (P1–P14)] as a source of stress (second “hit”). Control groups were left with their mothers (Fig. <xref ref-type="fig" rid="Fig5">5a</xref>). We tested whether microglia of offspring that were subjected to MS would show a stronger inflammatory response if the dams were first injected with IFNβ during pregnancy. For this, microglia were harvested from the pups on P15, and were analyzed by flow cytometry (Fig. <xref ref-type="fig" rid="Fig5">5b–g</xref>) and by immunofluorescence (Fig. <xref ref-type="fig" rid="Fig5">5h, i</xref>) to detect changes in their inflammatory and activation state. We started by measuring microglial TNFα expression by flow cytometry. To analyze the entire microglial population, including activated cells, we analyzed all the CD11b<sup>+</sup>CD45<sup>+</sup>cells (Fig. <xref ref-type="fig" rid="Fig5">5b</xref>). Most of the cells were CD11b<sup>int</sup>CD45<sup>int</sup>, and thus mainly represented the microglial population. The effect of maternal IFNβ treatment on microglial TNFα expression was calculated as the expression ratio relative to the relevant vehicle-treated group (control or MS). In both control and MS groups, the microglial TNFα mean fluorescence intensity (MFI) was significantly increased in samples derived from pups of dams treated with IFNβ, relative to vehicle (Fig. <xref ref-type="fig" rid="Fig5">5c, d</xref>). Calculations of effect size using Cohen’s <italic>d</italic> showed an effect size of <italic>d</italic> = 0.9838 for the IFNβ treatment in the control groups, and an effect size of <italic>d</italic> = 2.71 for IFNβ treatment in the MS groups. To verify that the changes in TNFα occurred mainly in the microglia and were not due infiltration of monocyte-derived macrophages, expression of Ly6C and CX3CR1 was measured for the CD11b<sup>+</sup>CD45<sup>+</sup>TNFα<sup>+</sup> cells (Fig. <xref ref-type="fig" rid="Fig5">5e</xref>). We found that, on average, 99.19 ± 0.037% of the cells were Ly6C<sup>−</sup>CX3CR1<sup>+</sup>, suggesting that TNFα was produced almost exclusively by microglia. In addition, we assessed microglial CD45 expression and found that following maternal treatment with IFNβ, the microglial CD45 MFI was higher only after MS, while expression in the control group remained unchanged (Fig. <xref ref-type="fig" rid="Fig5">5f</xref>). The results were not accompanied by any changes in the total number of microglia (Fig. <xref ref-type="fig" rid="Fig5">5g</xref>). Next, brains of the offspring from the MS groups (IFNβ and vehicle) were isolated, and analyzed using immunofluorescence to estimate microglial activation [<xref ref-type="bibr" rid="CR86">86</xref>]. Analysis of IBA-1 immunoreactivity in hippocampi revealed increased expression in sections derived from brains of IFNβ–MS pups, as compared with the vehicle-MS group (Fig. <xref ref-type="fig" rid="Fig5">5h, i</xref>). These results showed that maternal elevation of IFNβ increased the sensitivity of the offspring-derived microglia to postnatal stress. Finally, we tested whether IFNβ exacerbates the effect of MS at the behavioral level. Offspring from the MS groups (IFNβ and vehicle) were examined with the same battery of tests as described above (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>). Overall, we found different responses of the sexes to the treatment, with the main effect in females (Fig. <xref ref-type="fig" rid="Fig5">5j–n</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM3">2</xref>). At the age of 1 month, female offspring of the IFNβ–MS group buried a significantly higher number of marbles within the first 5 min of the test, relative to the vehicle-MS group (Fig. <xref ref-type="fig" rid="Fig5">5j</xref>). At the age of 3 months, IFNβ–MS female offspring showed a trend of burying a higher number of marbles, as compared with the vehicle-MS group (Fig. <xref ref-type="fig" rid="Fig5">5k</xref>). Those females also demonstrated a trend of spending more time in the open arms of the elevated plus maze (Fig. <xref ref-type="fig" rid="Fig5">5l</xref>), which may suggest increased risk-taking behavior, since they did not spend more time in closed arms, although they covered a significantly greater distance (Fig. <xref ref-type="fig" rid="Fig5">5m, n</xref>). These results demonstrate that maternal elevation of IFNβ renders the offspring less resilient to stressful conditions.<fig id="Fig5"><label>Fig. 5</label><caption><p>Maternal elevation of IFNβ increases the vulnerability of the offspring and their microglia to postnatal stress. <bold>a</bold> Pregnant females were i.v. injected on E14.5 with IFNβ (45,400 U) or vehicle. On postnatal days 1–14 (P1–P14), pups of the “two-hit” group were subjected to a 2-week maternal separation (MS) protocol. Pups of the control group were left with their mother. On P15, microglia were harvested from the pups, and were analyzed by flow cytometry and immunofluorescence. Offspring of the “two-hit” group were assessed at adolescence and adulthood with the same battery of behavioral tests, as described (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>). <bold>b</bold> Flow cytometry gating strategy for offspring’s microglia. <bold>c</bold> Flow cytometry analysis showing the effect of maternal IFNβ treatment on microglial TNFα expression (mean fluorescence intensity; MFI) as the ratio relative to the relevant vehicle-treated group (control or MS) (Control groups—Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.968<italic>, df</italic> = 14<italic>, *p</italic> = 0.0346, Cohen’s <italic>d</italic> = 0.9838; MS groups—Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 5.018<italic>, df</italic> = 15<italic>, ***p</italic> = 0.0002, Cohen’s <italic>d</italic> = 2.71<italic>)</italic>. <bold>d</bold> Flow cytometry representative TNFα MFI of offspring’s microglia. <bold>e</bold> Representative flow cytometry dot plot for microglial Ly6C and CX3CR1 expression. <bold>f</bold> Flow cytometry analyses showing the effect of maternal IFNβ treatment on microglial CD45 expression as the ratio relative to the relevant vehicle-treated group (control or MS) (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 2.578<italic>, df</italic> = 15<italic>, *p</italic> = 0.021), and <bold>g</bold> normalized number of microglia (to 13,500 live-gate events). <bold>c</bold>–<bold>g</bold> Representative results of one of two independent experiments. <italic>n</italic> = 6–11 offspring per group. <bold>h</bold> Immunofluorescence analysis and <bold>i</bold> representative images showing increased IBA-1 expression in hippocampi following maternal IFNβ treatment in the MS groups (Student’s <italic>t</italic> test: <italic>t</italic><sub>(two tailed)</sub> = 4.507<italic>, df</italic> = 12<italic>, ***p</italic> = 0.0007). DG -dentate gyrus, CA1 -Cornu Ammonis 1. <italic>n</italic> = 7 offspring per group. Scale bar, 100 µm. <bold>j</bold> Number of buried marbles during the first 5 min of the marble burying test by 1-month-old female offspring of the MS groups (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.895<italic>, df</italic> = 15<italic>, *p</italic> = 0.0388). <bold>k</bold> Number of buried marbles during the first 5 min of the marble burying test by 3-month-old female offspring of the MS groups (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.596<italic>, df</italic> = 13<italic>, p</italic> = 0.0673). <bold>l</bold> Time spent in open arms (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 1.651<italic>, df</italic> = 13<italic>, p</italic> = 0.0613), <bold>m</bold> in closed arms and <bold>n</bold> total distance (Student’s <italic>t</italic> test: <italic>t</italic><sub>(one tailed)</sub> = 3.906<italic>, df</italic> = 13, <italic>***p</italic> = 0.0009) covered by 3-month-old female offspring of the MS groups in the elevated plus maze. <italic>n</italic> = 6–9 offspring of 3 dams per group. <bold>c</bold>, <bold>f–h</bold>, <bold>j–n</bold> Data are presented as means ± s.e.m</p></caption><graphic id="d29e1836" xlink:href="41380_2019_604_Fig5_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec28" sec-type="discussion">
<title>Discussion</title>
<p id="Par57">In this study, we found that MIA affects the offspring, at least in part, through a Type-I interferon-dependent response of the dam. Specifically, we found that MIA leads to a reduction in microglial proliferation in the newborn offspring. The absence of IFN-I signaling resulted in increased newborn microglial proliferation, while IFN-I blockage mitigated the detrimental effect on microglia elicited by the MIA. Moreover, systemic elevation of IFNβ in dams, in the absence of MIA, resulted in a decrease in microglial proliferation in the newborn pups, and increased the sensitivity of the microglia to postnatal stress. In addition, the maternal IFNβ treatment led to alterations in behavior of the offspring in adolescence and adulthood, and contributed to increased vulnerability of the offspring to stressful conditions.</p>
<p id="Par58">MIA, induced by poly(I:C), is a well-established model, characterized by late onset behavioral deficits associated with autism and schizophrenia [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Although some studies found epigenetic changes in brains of the offspring [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>], the etiology and mechanisms forming the basis of this phenomenon are still unclear. Several studies examined changes in microglia of the pups following MIA by poly(I:C). In most cases, the activation state of microglia was assessed, but contradictory results have been reported; while some studies found increased microglial activation [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR89">89</xref>–<xref ref-type="bibr" rid="CR91">91</xref>], others failed to observe similar changes [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. Here, in order to study early effects of MIA, we used the poly(I:C) model and focused on early time points following the maternal treatment. We found reduced microglial proliferation in the newborn pups as a result of the maternal challenge.</p>
<p id="Par59">During development, microglia undergo distinct developmental stages associated with the changing microenvironment of the CNS, whereas different perturbations could lead to deviations in the maturation program [<xref ref-type="bibr" rid="CR74">74</xref>]. Our results, demonstrating reduced newborn’s microglial proliferation following MIA, could indicate premature differentiation of the microglia and unsynchronized development relative to the rest of the CNS, which could manifest in neuropsychiatric pathologies.</p>
<p id="Par60">One of the factors that could impair the developing embryo during maternal viral infection, is the maternal reaction to the virus. The antiviral response involves elevation of various inflammatory cytokines including IL-6, which was shown to induce endocrine changes in the placenta, leading to behavioral deficits in the offspring, and changes in gene-expression in their brains [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. The antiviral maternal reaction also includes upregulation of IFN-I, the first line of defense against viral infections in mammals [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR94">94</xref>]. A recently published paper demonstrated that interferon receptor-1 (IFNAR) signaling, due to Zika virus infection during pregnancy, inhibits the development of the placenta and induces fetal resorption [<xref ref-type="bibr" rid="CR95">95</xref>].</p>
<p id="Par61">Here, we used maternal poly(I:C) administration, one of the common rodent models for MIA, that mimics viral infection and was shown to upregulate inflammatory cytokines, including IFN-I [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Our results, 1 day after the MIA, demonstrated a IFN-I signature at the yolk sac, the origin of microglia progenitors [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>], and a subsequent regulatory effect of IFN-I on newborn’s microglia. Moreover, we showed that systemic elevation of IFNβ in dams was sufficient to impair the newborn’s microglial proliferation, and to increase the susceptibility of these cells to stress.</p>
<p id="Par62">IFNβ was demonstrated to have a regulatory role in microglia; it was shown that microglia of mice deficient in IFN regulatory factor 7 (IRF7) or IFNAR exhibited increased expression of the C-X-C motif chemokine ligand 13 (CXCL13), in homeostasis, and to a greater extent, in response to viral encephalitis [<xref ref-type="bibr" rid="CR96">96</xref>]. Moreover, our group previously showed that the microglial “phenotype-switch” in adulthood under injurious conditions is dependent on IFNβ signaling, and more specifically, on the transcription factor, IRF7 [<xref ref-type="bibr" rid="CR39">39</xref>]. In addition, several studies described a negative effect of IFN-I/IFNβ on microglia in various cases, such as in systemic lupus erythematosus [<xref ref-type="bibr" rid="CR97">97</xref>], in ageing [<xref ref-type="bibr" rid="CR46">46</xref>], and when chronically elevated in adulthood [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>].</p>
<p id="Par63">IFN-I signaling was demonstrated in the past as an important factor in arresting the reaction of myeloid cells to inflammatory stimuli, such as that mediated by IFNα, IFNγ, and lipopolysaccharide (LPS) [<xref ref-type="bibr" rid="CR98">98</xref>]. It was also suggested that IFN-I might be important during development for the regulation of cell proliferation and/or differentiation [<xref ref-type="bibr" rid="CR99">99</xref>], but this hypothesis has never been substantiated. Here, we found that newborn offspring that lack IFN-I signaling (IFNARKO mice) had a higher percentage of proliferating microglia, and in the case of MIA, this percentage was further increased. These results imply that IFN-I signaling is important for normal development of microglia. Yet, additional factors might be involved in regulation of microglial proliferation in homeostasis and following maternal poly(I:C) challenge, that are masked in the presence of IFN-I signaling [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. Assessment of some of these factors, such as the Type-II interferon, IFNγ, and the NF-kB-dependent inflammatory cytokine, TNFα, revealed that they did not elicit the same unique effect on the newborn’s microglia following maternal injection, as induced by maternal elevation of IFNβ. These results could explain, to some extent, differences in findings elicited by MIA using the viral mimetic poly(I:C) versus the bacterial endotoxin LPS, a toll-like receptor 4 ligand [<xref ref-type="bibr" rid="CR100">100</xref>]; LPS signaling induces a rapid production of NF-kB-dependent proinflammatory cytokines, while the production of IFN-I is delayed and in low levels [<xref ref-type="bibr" rid="CR101">101</xref>].</p>
<p id="Par64">IFN-I/IFNβ signaling was shown to affect several aspects of brain pathology and behavior. On the one hand, chronic IFN-I signaling in the ageing brain was demonstrated to negatively affect the choroid plexus and brain function [<xref ref-type="bibr" rid="CR102">102</xref>]. On the other hand, treatment of IFNβ was found to be beneficial in cases of multiple sclerosis [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>] and to exert a protective therapeutic effect in a mouse model of cerebral ischemia [<xref ref-type="bibr" rid="CR105">105</xref>]. Furthermore, IFN-I/IFNβ was shown to play a role in brain homeostasis, specifically in neurons. Neurons were found to maintain a homeostatic IFN-I level that is optimal for early control of viral infection [<xref ref-type="bibr" rid="CR106">106</xref>], while the lack of neuronal IFNβ signaling was shown to lead to defects in neuronal autophagy, to Lewy body accumulation, and to a Parkinson’s disease-like dementia [<xref ref-type="bibr" rid="CR107">107</xref>]. Here, we found that maternal IFNβ treatment led to behavioral alterations in adolescent and adult offspring that were manifested in a sex-specific manner. Specifically, we demonstrated that female offspring show a higher degree of repetitive behavior alongside reduced sociability, and that male offspring exhibit increased anxiety, all of which are hallmark symptoms observed in neuropsychiatric disorders, such as in autism- and schizophrenia-spectrum disorders [<xref ref-type="bibr" rid="CR108">108</xref>–<xref ref-type="bibr" rid="CR114">114</xref>]. The improved performance of female offspring in the spontaneous alternation test may suggest enhanced working memory of these mice, which was also reported in autism spectrum disorder patients [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. Furthermore, we also demonstrated exacerbated behavioral changes following MS in female offspring of mothers that were injected with IFNβ; these changes were characterized by increased repetitive behavior and reduced anxiety/increased risk-taking behavior. Although those behavioral manifestations are not the same as those observed following maternal treatment with IFNβ alone, the different outcome may reflect a different spectrum-related neuropsychiatric disease, such as mania [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR117">117</xref>].</p>
<p id="Par65">Taken together, our results attribute a novel role to IFN-I in regulation of microglia during development, provided that its expression is well balanced; any deviation from the homeostatic level could affect their fate. Our findings further highlight that maternal upregulation of IFN-I, in response to viral infection, could be harmful to the developing offspring. Accordingly, monitoring maternal IFN-I during pregnancy, and specifically during the dam’s illness, would allow timely therapeutic intervention to modulate IFN-I levels, and could thereby help prevent such pathologies in the offspring.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec29">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41380_2019_604_MOESM1_ESM.docx"><caption><p>Supplementary Figure Legends</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41380_2019_604_MOESM2_ESM.eps"><caption><p>Supplementary Figure 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41380_2019_604_MOESM3_ESM.eps"><caption><p>Supplementary Figure 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41380_2019_604_MOESM4_ESM.xlsx"><caption><p>Supplementary Table 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41380_2019_604_MOESM5_ESM.xlsx"><caption><p>Supplementary Table 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41380_2019_604_MOESM6_ESM.xlsx"><caption><p>Supplementary Table 3</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p>The online version of this article (10.1038/s41380-019-0604-0) contains supplementary material, which is available to authorized users.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Dr. Michal Arad for helping with the behavioral analyses, Carmel Sochen for helping with immunofluorescence analyses, Oz Rozenberg for handling the animals, and Shelley Schwarzbaum for proofreading. Prof. Michal Schwartz is supported by the Advanced European Research Council (ERC-2016-ADG 741744), the Israel Science Foundation-Legacy Heritage Biomedical Science Partnership-research (grant 1354/15), Israel Science Foundation (grant 991/16), Consolidated Anti-Aging Foundation Chicago (2016–2017) and Adelis Foundation (2018–2021). Prof. Michal Schwartz holds the Maurice and Ilse Katz Professorial Chair in Neuroimmunology.</p>
</ack>
<notes notes-type="data-availability">
<title>Data availability</title>
<p>The data of this study are available from the corresponding author upon reasonable request.</p>
</notes>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par66">The authors declare that they have no conflict of interest.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuckerman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring</article-title>
<source/>J Psychiatr Res
          <year>2005</year>
<volume>39</volume>
<fpage>311</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="pmid">15725430</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuckerman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation</article-title>
<source/>Psychopharmacol
          <year>2003</year>
<volume>169</volume>
<fpage>308</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Feldon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model</article-title>
<source/>PLoS ONE
          <year>2009</year>
<volume>4</volume>
<fpage>e6354</fpage>
<pub-id pub-id-type="pmid">19629183</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Yim</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring</article-title>
<source/>Science
          <year>2016</year>
<volume>351</volume>
<fpage>933</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">26822608</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Prenatal infection as a risk factor for schizophrenia</article-title>
<source/>Schizophr Bull
          <year>2006</year>
<volume>32</volume>
<fpage>200</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="pmid">16469941</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Culpepper</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rapaport</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies</article-title>
<source/>Prog Neuropsychopharmacol Biol Psychiatry
          <year>2013</year>
<volume>42</volume>
<fpage>92</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">22510462</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuchiya</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Byrne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Risk factors in relation to an emergence of bipolar disorder: a systematic review</article-title>
<source/>Bipolar Disord
          <year>2003</year>
<volume>5</volume>
<fpage>231</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">12895201</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Feldon</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models</article-title>
<source/>Neuropharmacology
          <year>2012</year>
<volume>62</volume>
<fpage>1308</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">21238465</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>ÉW</given-names>
</name>
<name>
<surname>O’Loughlin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sherwin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I: C</article-title>
<source/>Brain Behav Immun
          <year>2015</year>
<volume>48</volume>
<fpage>274</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">25900439</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Feldon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>BK</given-names>
</name>
</person-group>
<article-title>A review of the fetal brain cytokine imbalance hypothesis of schizophrenia</article-title>
<source/>Schizophr Bull
          <year>2009</year>
<volume>35</volume>
<fpage>959</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">18408229</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SEP</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garbett</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mirnics</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Maternal immune activation alters fetal brain development through interleukin-6</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<fpage>10695</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="pmid">17913903</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arrode-Brusés</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Brusés</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Maternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain</article-title>
<source/>J Neuroinflammation
          <year>2012</year>
<volume>9</volume>
<fpage>83</fpage>
<pub-id pub-id-type="pmid">22546005</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garbett</surname>
<given-names>Ka</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Kálmán</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Mirnics</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Effects of maternal immune activation on gene expression patterns in the fetal brain</article-title>
<source/>Transl Psychiatry
          <year>2012</year>
<volume>2</volume>
<fpage>e98</fpage>
<pub-id pub-id-type="pmid">22832908</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Activation of the maternal immune system induces endocrine changes in the placenta via IL-6</article-title>
<source/>Brain Behav Immun
          <year>2011</year>
<volume>25</volume>
<fpage>604</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">21195166</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexopoulou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Medzhitov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3</article-title>
<source/>Nature
          <year>2001</year>
<volume>413</volume>
<fpage>732</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">11607032</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Akira</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Recognition of viruses by innate immunity</article-title>
<source/>Immunol Rev
          <year>2007</year>
<volume>220</volume>
<fpage>214</fpage>
<lpage>24.</lpage>
<pub-id pub-id-type="pmid">17979849</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Mossman</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>Viral evasion strategies in Type I IFN signaling—a summary of recent developments</article-title>
<source/>Front Immunol
          <year>2016</year>
<volume>7</volume>
<fpage>498</fpage>
<pub-id pub-id-type="pmid">27891131</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García-Sastre</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Ten strategies of interferon evasion by viruses</article-title>
<source/>Cell Host Microbe
          <year>2017</year>
<volume>22</volume>
<fpage>176</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">28799903</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feigenson</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Kusnecov</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Silverstein</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Inflammation and the two-hit hypothesis of schizophrenia</article-title>
<source/>Neurosci Biobehav Rev
          <year>2014</year>
<volume>38</volume>
<fpage>72</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">24247023</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monte</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Mello</surname>
<given-names>BSF</given-names>
</name>
<name>
<surname>Borella</surname>
<given-names>VCM</given-names>
</name>
<name>
<surname>da Silva Araujo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>FER</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>FCFde</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Two-hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: study of sex differences and brain oxidative alterations</article-title>
<source/>Behav Brain Res
          <year>2017</year>
<volume>331</volume>
<fpage>30</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">28527693</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maynard</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Sikich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>LaMantia</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Neural development, cell-cell signaling, and the ‘two-hit’ hypothesis of schizophrenia</article-title>
<source/>Schizophr Bull
          <year>2001</year>
<volume>27</volume>
<fpage>457</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">11596847</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giovanoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Richetto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Voget</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Willi</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>1095</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">23449593</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nemeroff</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies</article-title>
<source/>Biol Psychiatry
          <year>2001</year>
<volume>49</volume>
<fpage>1023</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">11430844</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuda</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Long-lasting consequences of neonatal maternal separation on social behaviors in ovariectomized female mice</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<fpage>e33028</fpage>
<pub-id pub-id-type="pmid">22412981</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michell-Robinson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Touil</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Healy</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Durafourt</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Bar-Or</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Roles of microglia in brain development, tissue maintenance and repair</article-title>
<source/>Brain
          <year>2015</year>
<volume>138</volume>
<fpage>1138</fpage>
<lpage>59.</lpage>
<pub-id pub-id-type="pmid">25823474</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nayak</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>McGavern</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Microglia development and function</article-title>
<source/>Annu Rev Immunol
          <year>2014</year>
<volume>32</volume>
<fpage>367</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="pmid">24471431</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguzzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Microglia: scapegoat, saboteur, or something else?</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>156</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">23307732</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Christopherson</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The classical complement cascade mediates CNS synapse elimination</article-title>
<source/>Cell
          <year>2007</year>
<volume>131</volume>
<fpage>1164</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="pmid">18083105</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schafer</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Lehrman</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Kautzman</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mardinly</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner</article-title>
<source/>Neuron
          <year>2012</year>
<volume>74</volume>
<fpage>691</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="pmid">22632727</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paolicelli</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Bolasco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pagani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maggi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Scianni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Panzanelli</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic pruning by microglia is necessary for normal brain development</article-title>
<source/>Science
          <year>2011</year>
<volume>333</volume>
<fpage>1456</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">21778362</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shigemoto-Mogami</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hoshikawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Sekino</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone</article-title>
<source/>J Neurosci
          <year>2014</year>
<volume>34</volume>
<fpage>2231</fpage>
<lpage>43.</lpage>
<pub-id pub-id-type="pmid">24501362</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunningham</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Martinez-Cerdeno</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Noctor</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Microglia regulate the number of neural precursor cells in the developing cerebral cortex</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<fpage>4216</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">23467340</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prinz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Priller</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease</article-title>
<source/>Nat Rev Neurosci
          <year>2014</year>
<volume>15</volume>
<fpage>300</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">24713688</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothhammer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Borucki</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Tjon</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>C-C</given-names>
</name>
<name>
<surname>Ardura-Fabregat</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglial control of astrocytes in response to microbial metabolites</article-title>
<source/>Nature
          <year>2018</year>
<volume>557</volume>
<fpage>724</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">29769726</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kreutzberg</surname>
<given-names>GW</given-names>
</name>
</person-group>
<article-title>Microglia: a sensor for pathological events in the CNS</article-title>
<source/>Trends Neurosci
          <year>1996</year>
<volume>19</volume>
<fpage>312</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">8843599</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pivneva</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Microglia in normal condition and pathology</article-title>
<source/>Fiziol Zh
          <year>2008</year>
<volume>54</volume>
<fpage>81</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">19058517</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deczkowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Amit</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Microglial immune checkpoint mechanisms</article-title>
<source/>Nat Neurosci
          <year>2018</year>
<volume>21</volume>
<fpage>779</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">29735982</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butovsky</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Jedrychowski</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Cialic</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lanser</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Gabriely</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a unique TGF-β–dependent molecular and functional signature in microglia</article-title>
<source/>Nat Neurosci
          <year>2013</year>
<volume>17</volume>
<fpage>131</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">24316888</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matcovitch</surname>
<given-names>O</given-names>
</name>
<name>
<surname>David</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Barnett-Itzhaki</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Keren-Shaul</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Blecher-Gonen</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic exposure to TGFβ1 regulates myeloid cell inflammatory response in an IRF7-dependent manner</article-title>
<source/>EMBO J
          <year>2014</year>
<volume>33</volume>
<fpage>2906</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">25385836</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yanai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Negishi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Asagiri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IRF-7 is the master regulator of type-I interferon-dependent immune responses</article-title>
<source/>Nature
          <year>2005</year>
<volume>434</volume>
<fpage>772</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">15800576</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cronk</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Derecki</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lampano</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Smirnov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli</article-title>
<source/>Immunity
          <year>2015</year>
<volume>42</volume>
<fpage>679</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">25902482</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cusimano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zambito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Finardi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Capotondo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Garcia-Manteiga</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis</article-title>
<source/>Cell Death Dis
          <year>2018</year>
<volume>9</volume>
<fpage>250</fpage>
<pub-id pub-id-type="pmid">29445154</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobo-Silva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carriche</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Roque</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saraiva</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Interferon-β regulates the production of IL-10 by toll-like receptor-activated microglia</article-title>
<source/>Glia
          <year>2017</year>
<volume>65</volume>
<fpage>1439</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">28617991</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zeller</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Raasch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kierdorf</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Frenzel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ketscher</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>USP18 lack in microglia causes destructive interferonopathy of the mouse brain</article-title>
<source/>EMBO J
          <year>2015</year>
<volume>34</volume>
<fpage>1612</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">25896511</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meuwissen</surname>
<given-names>MEC</given-names>
</name>
<name>
<surname>Schot</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Buta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oudesluijs</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tinschert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Speer</surname>
<given-names>SD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome</article-title>
<source/>J Exp Med
          <year>2016</year>
<volume>213</volume>
<fpage>1163</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">27325888</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deczkowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matcovitch-Natan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Tsitsou-Kampeli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ben-Hamo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dvir-Szternfeld</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Spinrad</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<fpage>717</fpage>
<pub-id pub-id-type="pmid">28959042</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smolders</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smolders</surname>
<given-names>SMT</given-names>
</name>
<name>
<surname>Swinnen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gärtner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rigo</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Legendre</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal immune activation evoked by polyinosinic:polycytidylic acid does not evoke microglial cell activation in the embryo</article-title>
<source/>Front Cell Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>301</fpage>
<pub-id pub-id-type="pmid">26300736</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giovanoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Notter</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Richetto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Labouesse</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Vuillermot</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Riva</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Late prenatal immune activation causes hippocampal deficits in the absence of persistent inflammation across aging</article-title>
<source/>J Neuroinflammation
          <year>2015</year>
<volume>12</volume>
<fpage>221</fpage>
<pub-id pub-id-type="pmid">26602365</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giovanoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Weber-Stadlbauer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schedlowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies</article-title>
<source/>Brain Behav Immun
          <year>2016</year>
<volume>55</volume>
<fpage>25</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">26408796</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patrich</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Piontkewitz</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Peretz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Attali</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Maternal immune activation produces neonatal excitability defects in offspring hippocampal neurons from pregnant rats treated with poly I:C</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>19106</fpage>
<pub-id pub-id-type="pmid">26742695</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>van Praag</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice</article-title>
<source/>Brain Behav Immun
          <year>2015</year>
<volume>45</volume>
<fpage>60</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">25449671</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coiro</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Padmashri</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Suresh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Spartz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pendyala</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders</article-title>
<source/>Brain Behav Immun
          <year>2015</year>
<volume>50</volume>
<fpage>249</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">26218293</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bialas</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>de Rivera</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Kamitaki</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia risk from complex variation of complement component 4</article-title>
<source/>Nature
          <year>2016</year>
<volume>530</volume>
<fpage>177</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">26814963</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Paolicelli</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Sforazzini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Weinhard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bolasco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pagani</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior</article-title>
<source/>Nat Neurosci
          <year>2014</year>
<volume>17</volume>
<fpage>400</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">24487234</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eßlinger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wachholz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Manitz</surname>
<given-names>M-P</given-names>
</name>
<name>
<surname>Plümper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Juckel</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia associated sensory gating deficits develop after adolescent microglia activation</article-title>
<source/>Brain Behav Immun
          <year>2016</year>
<volume>58</volume>
<fpage>99</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="pmid">27235930</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prinz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mildner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Knobeloch</surname>
<given-names>K-P</given-names>
</name>
<name>
<surname>Hanisch</surname>
<given-names>U-K</given-names>
</name>
<name>
<surname>Raasch</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system</article-title>
<source/>Immunity
          <year>2008</year>
<volume>28</volume>
<fpage>675</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">18424188</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aliberti</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Graemmel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sunshine</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kreutzberg</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Sher</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion</article-title>
<source/>Mol Cell Biol
          <year>2000</year>
<volume>20</volume>
<fpage>4106</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">10805752</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Nyffeler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schwendener</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Knuesel</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Feldon</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge</article-title>
<source/>Neuropsychopharmacology
          <year>2008</year>
<volume>33</volume>
<fpage>441</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">17443130</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Nyffeler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Urwyler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schedlowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Knuesel</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology</article-title>
<source/>J Neurosci
          <year>2006</year>
<volume>26</volume>
<fpage>4752</fpage>
<lpage>62.</lpage>
<pub-id pub-id-type="pmid">16672647</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheehan</surname>
<given-names>KCF</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Bruce</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Heutel</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection</article-title>
<source/>J Interferon Cytokine Res
          <year>2006</year>
<volume>26</volume>
<fpage>804</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">17115899</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belardelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gabriele</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Proietti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sestili</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Peretti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rozera</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synergistic anti-tumor effects of combined IL-1/IFN-α/β therapy in mice injected with met astatic friend erythroleukemia cells</article-title>
<source/>Int J Cancer
          <year>1991</year>
<volume>49</volume>
<fpage>274</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">1879971</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H-Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z-K</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-dose interferon-γ promotes abortion in mice by suppressing Treg and Th17 polarization</article-title>
<source/>J Inter Cytokine Res
          <year>2014</year>
<volume>34</volume>
<fpage>394</fpage>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Chaudhri</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Tumor necrosis factor in malaria-induced abortion</article-title>
<source/>Am J Trop Med Hyg
          <year>1988</year>
<volume>39</volume>
<fpage>246</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">3177738</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roque</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ochoa-Zarzosa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Torner</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Maternal separation activates microglial cells and induces an inflammatory response in the hippocampus of male rat pups, independently of hypothalamic and peripheral cytokine levels</article-title>
<source/>Brain Behav Immun
          <year>2016</year>
<volume>55</volume>
<fpage>39</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">26431692</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deacon</surname>
<given-names>RMJ</given-names>
</name>
</person-group>
<article-title>Digging and marble burying in mice: simple methods for in vivo identification of biological impacts</article-title>
<source/>Nat Protoc
          <year>2006</year>
<volume>1</volume>
<fpage>122</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">17406223</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Burant</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bui</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yuva-Paylor</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety</article-title>
<source/>Psychopharmacology
          <year>2009</year>
<volume>204</volume>
<fpage>361</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">19189082</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walf</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>The use of the elevated plus maze as an assay of anxiety-related behavior in rodents</article-title>
<source/>Nat Protoc
          <year>2007</year>
<volume>2</volume>
<fpage>322</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">17406592</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nadler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barbaro</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Johns</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Magnuson</surname>
<given-names>TR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice</article-title>
<source/>Genes Brain Behav
          <year>2004</year>
<volume>3</volume>
<fpage>287</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="pmid">15344922</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gould</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Dao</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Kovacsics</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>The open field test. in mood and anxiety related phenotypes in mice</article-title>
<source/>Neuromethods
          <year>2009</year>
<volume>42</volume>
<fpage>1</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<mixed-citation publication-type="other">Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015;96:e52434.</mixed-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>RN</given-names>
</name>
</person-group>
<article-title>The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory</article-title>
<source/>Neurosci Biobehav Rev
          <year>2004</year>
<volume>28</volume>
<fpage>497</fpage>
<lpage>505</lpage>
<pub-id pub-id-type="pmid">15465137</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kouzu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Moriya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takeshima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yoshioka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus</article-title>
<source/>Mol Brain Res
          <year>2000</year>
<volume>76</volume>
<fpage>142</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">10719224</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaitin</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Kenigsberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Keren-Shaul</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Elefant</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zaretsky</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types</article-title>
<source/>Science
          <year>2014</year>
<volume>343</volume>
<fpage>776</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">24531970</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matcovitch-Natan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Giladi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vargas Aguilar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Spinrad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sarrazin</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglia development follows a stepwise program to regulate brain homeostasis</article-title>
<source/>Science
          <year>2016</year>
<volume>353</volume>
<fpage>aad8670</fpage>
<pub-id pub-id-type="pmid">27338705</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trapnell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pachter</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>TopHat: discovering splice junctions with RNA-Seq</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<fpage>1105</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">19289445</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Benner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Spann</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bertolino</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Laslo</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title>
<source/>Mol Cell
          <year>2010</year>
<volume>38</volume>
<fpage>576</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">20513432</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashburner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Botstein</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene ontology: tool for the unification of biology. The gene ontology consortium</article-title>
<source/>Nat Genet
          <year>2000</year>
<volume>25</volume>
<fpage>25</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">10802651</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carbon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dietze</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Mungall</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Munoz-Torres</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expansion of the gene ontology knowledgebase and resources: the gene ontology consortium</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<fpage>D331</fpage>
<lpage>8.</lpage>
<pub-id pub-id-type="pmid">27899567</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eden</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lipson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yogev</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yakhini</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Discovering motifs in ranked lists of DNA sequences</article-title>
<source/>PLoS Comput Biol
          <year>2007</year>
<volume>3</volume>
<fpage>0508</fpage>
<lpage>22.</lpage>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eden</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Navon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Steinfeld</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lipson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yakhini</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists</article-title>
<source/>BMC Bioinform
          <year>2009</year>
<volume>10</volume>
<fpage>48</fpage>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rusinova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Masse</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cumming</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interferome v2.0: an updated database of annotated interferon-regulated genes</article-title>
<source/>Nucleic Acids Res
          <year>2013</year>
<volume>41</volume>
<fpage>D1040</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">23203888</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginhoux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Greter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leboeuf</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nandi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>See</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gokhan</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages</article-title>
<source/>Science
          <year>2010</year>
<volume>330</volume>
<fpage>841</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">20966214</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gomez Perdiguero</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chorro</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Szabo-Rogers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cagnard</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kierdorf</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A lineage of myeloid cells independent of Myb and hematopoietic stem cells</article-title>
<source/>Science
          <year>2012</year>
<volume>336</volume>
<fpage>86</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">22442384</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tak</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Firestein</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>NF-kappaB: a key role in inflammatory diseases</article-title>
<source/>J Clin Investig
          <year>2001</year>
<volume>107</volume>
<fpage>7</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">11134171</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lelios</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Croxford</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Microglia versus myeloid cell nomenclature during brain inflammation</article-title>
<source/>Front Immunol
          <year>2015</year>
<volume>6</volume>
<fpage>249</fpage>
<pub-id pub-id-type="pmid">26074918</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dembo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fukuuchi</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain</article-title>
<source/>Stroke
          <year>2001</year>
<volume>32</volume>
<fpage>1208</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">11340235</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basil</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Dempster</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>P-C</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>CCY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain</article-title>
<source/>Transl Psychiatry
          <year>2014</year>
<volume>4</volume>
<fpage>e434</fpage>
<pub-id pub-id-type="pmid">25180573</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richetto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Massart</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Weber-Stadlbauer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Riva</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Genome-wide DNA methylation changes in a mouse model of infection-mediated neurodevelopmental disorders</article-title>
<source/>Biol Psychiatry
          <year>2017</year>
<volume>81</volume>
<fpage>265</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">27769567</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juckel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Manitz</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Brüne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Friebe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heneka</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Microglial activation in a neuroinflammational animal model of schizophrenia—a pilot study</article-title>
<source/>Schizophr Res
          <year>2011</year>
<volume>131</volume>
<fpage>96</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">21752601</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manitz</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Plümper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Demir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ahrens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eßlinger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wachholz</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Flow cytometric characterization of microglia in the offspring of polyI:C treated mice</article-title>
<source/>Brain Res
          <year>2016</year>
<volume>1636</volume>
<fpage>172</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">26872595</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattei</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ferrai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Guneykaya</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Buonfiglioli</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment</article-title>
<source/>Transl Psychiatry
          <year>2017</year>
<volume>7</volume>
<fpage>e1120</fpage>
<pub-id pub-id-type="pmid">28485733</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garay</surname>
<given-names>Pa</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>McAllister a.</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development</article-title>
<source/>Brain Behav Immun
          <year>2013</year>
<volume>31</volume>
<fpage>54</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">22841693</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Harmeier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giovanoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease</article-title>
<source/>Neuropharmacology
          <year>2013</year>
<volume>73</volume>
<fpage>56</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">23707483</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haller</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kochs</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The interferon response circuit: Induction and suppression by pathogenic viruses</article-title>
<source/>Virology
          <year>2006</year>
<volume>344</volume>
<fpage>119</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">16364743</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yockey</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Jurado</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Millet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rakib</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Milano</surname>
<given-names>KM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Type I interferons instigate fetal demise after Zika virus infection</article-title>
<source/>Sci Immunol
          <year>2018</year>
<volume>3</volume>
<fpage>eaao1680</fpage>
<pub-id pub-id-type="pmid">29305462</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rainey-Barger</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Blakely</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Irani</surname>
<given-names>DN</given-names>
</name>
</person-group>
<article-title>Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13</article-title>
<source/>Glia
          <year>2014</year>
<volume>62</volume>
<fpage>1452</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">24829092</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bialas</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Presumey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van der Poel</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Lapchak</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Mesin</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglia-dependent synapse loss in type I interferon-mediated lupus</article-title>
<source/>Nature
          <year>2017</year>
<volume>546</volume>
<fpage>539</fpage>
<pub-id pub-id-type="pmid">28614301</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Hertzog</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Sumarsono</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Tymms</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1995</year>
<volume>92</volume>
<fpage>11284</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">7479980</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertzog P</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hwang S</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kola</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Role of interferons in the regulation of cell proliferation, differentiation, and development</article-title>
<source/>Mol Reprod Dev
          <year>1994</year>
<volume>39</volume>
<fpage>226</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">7530016</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems</article-title>
<source/>Biol Psychiatry
          <year>2014</year>
<volume>75</volume>
<fpage>307</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">23938317</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pålsson-McDermott</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>O’Neill</surname>
<given-names>LAJ</given-names>
</name>
</person-group>
<article-title>Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4</article-title>
<source/>Immunology
          <year>2004</year>
<volume>113</volume>
<fpage>153</fpage>
<lpage>62.</lpage>
<pub-id pub-id-type="pmid">15379975</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baruch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Deczkowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>David</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Castellano</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kertser</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aging-induced type I interferon response at the choroid plexus negatively affects brain function</article-title>
<source/>Science
          <year>2014</year>
<volume>346</volume>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">25147279</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Río</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tintoré</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Téllez</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Galán</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Montalban</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Interferon beta in relapsing–remitting multiple sclerosis</article-title>
<source/>J Neurol
          <year>2005</year>
<volume>252</volume>
<fpage>795</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="pmid">15772741</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Group TIMSS.</collab>
</person-group>
<article-title>Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB multiple sclerosis study group</article-title>
<source/>Neurology
          <year>1993</year>
<volume>43</volume>
<fpage>655</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">8469318</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuo</surname>
<given-names>P-C</given-names>
</name>
<name>
<surname>Scofield</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>I-C</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>F-L</given-names>
</name>
<name>
<surname>Ganea</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>J-H</given-names>
</name>
</person-group>
<article-title>Interferon-β modulates inflammatory response in cerebral ischemia</article-title>
<source/>J Am Heart Assoc
          <year>2016</year>
<volume>5</volume>
<fpage>1</fpage>
<lpage>16.</lpage>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavanaugh</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Holmgren</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rall</surname>
<given-names>GF</given-names>
</name>
</person-group>
<article-title>Homeostatic interferon expression in neurons is sufficient for early control of viral infection</article-title>
<source/>J Neuroimmunol
          <year>2015</year>
<volume>279</volume>
<fpage>11</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">25669994</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ejlerskov</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hultberg</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ambjørn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuss</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lack of neuronal IFN-β-IFNAR causes Lewy body- and Parkinson’s disease-like dementia</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<fpage>324</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">26451483</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Elsabbagh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Veenstra-Vanderweele</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorder</article-title>
<source/>Lancet
          <year>2018</year>
<volume>392</volume>
<fpage>508</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">30078460</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hommer</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Swedo</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Schizophrenia and autism-related disorders</article-title>
<source/>Schizophr Bull
          <year>2015</year>
<volume>41</volume>
<fpage>313</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">25634913</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaebel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Barch</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Bustillo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gur</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Heckers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Malaspina</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Definition and description of schizophrenia in the DSM-5</article-title>
<source/>Schizophr Res
          <year>2013</year>
<volume>150</volume>
<fpage>3</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">23800613</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Schizophrenia</article-title>
<source/>Lancet
          <year>2016</year>
<volume>388</volume>
<fpage>86</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">26777917</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Temmingh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Anxiety in patients with schizophrenia: epidemiology and management</article-title>
<source/>CNS Drugs
          <year>2015</year>
<volume>29</volume>
<fpage>819</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">26482261</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<mixed-citation publication-type="other">American Psychiatric Association. Neurodevelopmental disorders. In: Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association; Arlington, 2013. 10.1176/appi.books.9780890425596.dsm01.</mixed-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<mixed-citation publication-type="other">American Psychiatric Association. Schizophrenia spectrum and other psychotic disorders. In: Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association; Arlington, 2013. 10.1176/appi.books.9780890425596.dsm02.</mixed-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgin</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>BF</given-names>
</name>
</person-group>
<article-title>Spatial cognition in autism spectrum disorders: superior, impaired, or just intact?</article-title>
<source/>J Autism Dev Disord
          <year>2005</year>
<volume>35</volume>
<fpage>729</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">16328713</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beversdorf</surname>
<given-names>DQ</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Crucian</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Keillor</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased discrimination of ‘false memories’ in autism spectrum disorder</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2000</year>
<volume>97</volume>
<fpage>8734</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">10900024</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miró</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dreisow</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Strohmaier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Breuer</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Studies in humans and mice implicate neurocan in the etiology of mania</article-title>
<source/>Am J Psychiatry
          <year>2012</year>
<volume>169</volume>
<fpage>982</fpage>
<lpage>90.</lpage>
<pub-id pub-id-type="pmid">22952076</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>